The DOI matches its Crossref record; 3 of the 7 references it cites were found in a registry or an index, and 4 are not checked yet.
Guide to Receptors and Channels (GRAC), 5th edition
Open accessAbstract
The Fifth Edition of the 'Guide to Receptors and Channels' is a compilation of the major pharmacological targets divided into seven sections: G protein-coupled receptors, ligand-gated ion channels, ion channels, catalytic receptors, nuclear receptors, transporters and enzymes. These are presented with nomenclature guidance and summary information on the best available pharmacological tools, alongside suggestions for further reading. Available alongside this publication is a portal at http://www.GuideToPharmacology.org which is produced in close association with NC-IUPHAR and allows free online access to the information presented in the Fifth Edition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Functional CRF 1 receptors are essential for the activation of the endocrine response to stress [169].”
From Anxiety, depression, and the microbiome: A role for gut peptides (2018) · cites this paper as [169]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kanai, Y., & Hediger, M. A. (2004) · Pfl�gers Archiv European Journal of Physiology · doi:10.1007/s00424-003-1146-4 · Cited by 450
The thermo‐TRP ion channel family: properties and therapeutic implications
Vay, L., Gu, C., & McNaughton, P. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01601.x · Cited by 313
Guide to Receptors and Channels (GRAC), 4th edition
Alexander, S. P. H., & Peters, J. A. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00499.x · Cited by 249
Self-citationThe oligomeric state sets GABAB receptor signalling efficacy
Comps‐Agrar, L., Kniazeff, J., Nørskov-Lauritsen, L., Maurel, D., Gassmann, M., Gregor, N., Prézeau, L., Bettler, B., Durroux, T., Trinquet, E., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.143 · Cited by 103
Lan, R., Lu, Q., Fan, P., Gatley, J. S., Volkow, N. D., Fernando, S. R., Pertwee, R. G., & Makriyannis, A. (1999) · AAPS PharmSci · doi:10.1208/ps010204 · Cited by 98
X. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes.
Vanhoutte, P. M., Humphrey, P. P. A., & Spedding, M. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06936-4 · Cited by 78
Goursaud, S., Focant, M. C., Berger, J. V., Nizet, Y., Maloteaux, J., & Hermans, E. (2011) · The FASEB Journal · doi:10.1096/fj.11-182337 · Cited by 14
Cited by
Sorted by citations
Items 601–700 of 1,000
Sticht, M. A., Long, J. Z., Rock, E. M., Limebeer, C. L., Mechoulam, R., Cravatt, B. F., & Parker, L. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01407.x · Cited by 54
Behringer, E. J., Socha, M. J., Polo‐Parada, L., & Segal, S. S. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01814.x · Cited by 54
Barton, M. (2016) · Steroids · doi:10.1016/j.steroids.2016.02.016 · Cited by 57
Kun, A., Matchkov, V. V., Stankevıčıus, E., Nardi, A. E., Hughes, A. D., Hj, K., Demnitz, J., & Simonsen, U. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00404.x · Cited by 54
Tymvios, C., Moore, C., Jones, S., Solomon, A., Sanz‐Rosa, D., & Emerson, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00408.x · Cited by 54
Gamaleddin, I., Guranda, M., Goldberg, S. R., & Foll, B. L. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01440.x · Cited by 53
Sacherer, M., Sedej, S., Wakula, P., Wallner, M., Vos, M., Kockskämper, J., Stiegler, P., Sereinigg, M., von Lewinski, D., Antoons, G., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01995.x · Cited by 53
Effects of drug interactions on biotransformation and antiplatelet effect of clopidogrelin vitro
Zahno, A., Brecht, K., Bodmer, M., Bur, D., Tsakiris, D. A., & Krähenbühl, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00881.x · Cited by 53
Ciccarelli, M., Sorriento, D., Cipolletta, E., Santulli, G., Fusco, A., Zhou, R., Eckhart, A. D., Peppel, K., Koch, W. J., Trimarco, B., et al. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01078.x · Cited by 53
Feng, W., Song, Y., Chen, C., Lu, Z., & Zhang, Y. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00558.x · Cited by 53
Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner
Myöhänen, T. T., Tenorio‐Laranga, J., Jokinen, B., Sánchez, R. V., Moreno-Baylach, M. J., Garcia-Horsman, A., & Männistö, P. T. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01146.x · Cited by 53
Estiú, M. C., Monte, M. J., Rivas, L., Moirón, M. D. C., Gomez‐Rodriguez, L., Rodriguez‐Bravo, T., Marı́n, J. J. G., & Macı́as, R. I. R. (2014) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12480 · Cited by 53
Chen, G., Zeng, B., Eastmond, S., Elsenussi, S. E., Boa, A. N., & Xu, S. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02058.x · Cited by 53
Matera, M. G., Calzetta, L., Passeri, D., Facciolo, F., Rendina, E. A., Page, C. P., Cazzola, M., & Orlandi, A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01339.x · Cited by 53
Barragán‐Iglesias, P., Mendoza-Garcés, L., Pineda-Farías, J. B., Solano-Olivares, V., Rodríguez‐Silverio, J., Flores‐Murrieta, F. J., Granados‐Soto, V., & Rocha-González, H. I. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.11.001 · Cited by 53
A ménage à trois made in heaven: G-protein-coupled receptors, lipids and TRP channels
Kukkonen, J. P. (2011) · Cell Calcium · doi:10.1016/j.ceca.2011.04.005 · Cited by 52
Stress-Induced Pain: A Target for the Development of Novel Therapeutics
Johnson, A. C., & Meerveld, B. G. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.218065 · Cited by 57
Grilli, M., Neri, E., Zappettini, S., Massa, F., Bisio, A., Romussi, G., Marchi, M., & Pittaluga, A. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.07.023 · Cited by 53
Plasma Membrane Mechanical Stress Activates TRPC5 Channels
Shen, B. Q., Wong, C., Lau, O.-C., Woo, T. H. S., Bai, S., Huang, Y., & Yao, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0122227 · Cited by 53
Pharmacology of transient receptor potential melastatin channels in the vasculature
Zholos, A. V. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00649.x · Cited by 52
Drug-like Antagonists of P2Y Receptors—From Lead Identification to Drug Development
Conroy, S., Kindon, N. D., Kellam, B., & Stocks, M. J. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01972 · Cited by 53
Ling, W. C., Liu, J., Lau, C. W., Murugan, D. D., Mustafa, M. R., & Huang, Y. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.04.007 · Cited by 53
Kizub, I., Pavlova, O. O., Johnson, C. D., Soloviev, A. I., & Zholos, A. V. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00666.x · Cited by 53
Rose, R. H., Briddon, S. J., & Hill, S. J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01640.x · Cited by 53
Hui, D. Y., Cope, M. J. T. V., Labonté, E. D., Chang, H., Shao, J., Goka, E., Abousalham, A., Charmot, D., & Buysse, J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00308.x · Cited by 53
Ding, Z., & Raffa, R. B. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00209.x · Cited by 53
Hu, G., Oboukhova, E., Kumar, S., Sturek, M. S., & Obukhov, A. G. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0350 · Cited by 53
Shen, W., Hao, J., Feng, Z., Tian, C., Chen, W., Packer, L., Shi, X., Zang, W., & Liu, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01134.x · Cited by 52
Lin, W., Lin, C., Cheng, H. K., & Yang, C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01312.x · Cited by 54
Pharmacological characterization of the new histamine H4receptor agonist VUF 8430
Lim, H. D., Adami, M., Guaita, E., Werfel, T., Smits, R. A., de Esch, I. J. P., Bakker, R. A., Gutzmer, R., Coruzzi, G., & Leurs, R. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00200.x · Cited by 52
Merighi, S., Gessi, S., Varani, K., Simioni, C., Fazzi, D., Mirandola, P., & Borea, P. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01673.x · Cited by 52
RetractedN‐arachidonyl‐glycine modulates synaptic transmission in superficial dorsal horn
Jeong, H., Vandenberg, R. J., & Vaughan, C. W. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00935.x · Cited by 52
Predicting the emetic liability of novel chemical entities: a comparative study
du Sert, N. P., Holmes, A. M., Wallis, R., & Andrews, P. L. R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01669.x · Cited by 52
Role of Reactive Oxygen Species in Hyperadrenergic Hypertension
Gayen, J. R., Zhang, K., RamachandraRao, S., Mahata, M., Chen, Y., Kim, H., Naviaux, R. K., Sharma, K., Mahata, S. K., & O’Connor, D. T. (2010) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.109.924050 · Cited by 52
Localisation of pre- and postsynaptic cholinergic markers in the human brain.
Wevers, A. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.02.025 · Cited by 52
Kabli, N., Martin, N. A., Fan, T., Nguyen, T., Hasbi, A., Balboni, G., O’Dowd, B. F., & George, S. R. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00944.x · Cited by 52
Electrophysiological classification of P2X7 receptors in rat cultured neocortical astroglia
Nörenberg, W., Schunk, J., Fischer, W., Sobottka, H., Riedel, T., Oliveira, J. F., Franke, H., & Illés, P. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00736.x · Cited by 52
Pierno, S., Camerino, G. M., Cippone, V., Rolland, J., Desaphy, J., Luca, A. D., Liantonio, A., Bianco, G., Kunic, J., George, A. L., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00079.x · Cited by 52
Leishman, E., Cornett, B., Spork, K., Straiker, A. J., Mackie, K., & Bradshaw, H. B. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.04.020 · Cited by 52
Juarez, J. F. B., Harper, A. J., Judge, P. J., Tonge, S. R., & Watts, A. G. (2019) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2019.03.008 · Cited by 52
Hassan, M. I., Boosen, M., Schaefer, L., Kozlowska, J., Eisel, F., von Knethen, A., Beck, M., Hemeida, R. A. M., El‐Moselhy, M. A., Hamada, F. M. A., et al. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01949.x · Cited by 52
Maccarrone, M., Bernardi, G., Finazzi‐Agrò, A., & Centonze, D. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01277.x · Cited by 53
Campia, I., Lussiana, C., Pescarmona, G., Ghigo, D., Bosìa, A., & Riganti, C. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00465.x · Cited by 51
Pharmacological characterization of a small‐molecule agonist for the chemokine receptor CXCR3
Scholten, D. J., Canals, M., Wijtmans, M., de Munnik, S., Nguyen, P., Verzijl, D., de Esch, I. J. P., Vischer, H. F., Smit, M. J., & Leurs, R. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01648.x · Cited by 49
Nimodipine inhibits IL‐1β release stimulated by amyloid β from microglia
Sanz, J., Chiozzi, P., Colaianna, M., Zotti, M., Ferrari, D., Trabace, L., Zuliani, G., & Virgilio, F. D. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02112.x · Cited by 52
Bartels, C., Looby, M., Séchaud, R., & Kaiser, G. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12118 · Cited by 51
Lungo, M. D., Melchiorre, M., Guandalini, L., Sartiani, L., Mugelli, A., Koncz, I., Szél, T., Varró, A., Romanelli, M. N., & Cerbai, E. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01782.x · Cited by 51
da Costa, R., Motta, E. M., Dutra, R. C., Manjavachi, M. N., Bento, A. F., Malinsky, F. R., Pesquero, J. B., & Calixto, J. Β. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01408.x · Cited by 51
Nakamura, A., Hasegawa, M., Minami, K., Kanbara, T., Tomii, T., Nishiyori, A., Narita, M., Suzuki, T., & Kato, A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02139.x · Cited by 51
Khom, S., Strommer, B., Ramharter, J., Schwarz, T., Schwarzer, C., Erker, T., Ecker, G. F., Mulzer, J., & Hering, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00865.x · Cited by 51
Quérée, P., Peters, S., & Sharp, T. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00406.x · Cited by 51
Broadstock, M., Austin, P. J., Betts, M. J., & Duty, S. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01515.x · Cited by 51
Capasso, R., Aviello, G., Romano, B., Borrelli, F., PETROCELLIS, L. D., Marzo, V. D., & Izzo, A. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01703.x · Cited by 51
Choi, H. J., Kang, K. S., Fukui, M., & Zhu, B. T. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01041.x · Cited by 50
Quinton, L., Girard, E., Maïga, A., Rekik, M., Lluel, P., Masuyer, G., Larregola, M., Marquer, C., Ciolek, J., Magnin, T., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00532.x · Cited by 51
Heterologously expressed formyl peptide receptor 2 (FPR2/ALX) does not respond to lipoxin A4
Hanson, J., Ferreirós, N., Pirotte, B., Geißlinger, G., & Offermanns, S. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.04.019 · Cited by 51
Ganella, D. E., Ma, S., & Gundlach, A. L. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00128 · Cited by 54
The role of prostanoids in urinary bladder physiology
Rahnama’i, M. S., Kerrebroeck, P. V., Wachter, S. D., & van Koeveringe, G. A. (2012) · Nature Reviews Urology · doi:10.1038/nrurol.2012.33 · Cited by 51
Radovits, T., Bömicke, T., Kökény, G., Arif, R., Loganathan, S., Kécsán, K., Korkmaz, S., Barnucz, E., Sandner, P., Karck, M., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00098.x · Cited by 51
PETROCELLIS, L. D., Moriello, A. S., Imperatore, R., Cristino, L., Starowicz, K., & Marzo, V. D. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02122.x · Cited by 51
Production of a specific extracellular inhibitor of TRPM3 channels
Naylor, J., Milligan, C. J., Zeng, F., Jones, C. A., & Beech, D. J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.283 · Cited by 51
Stroes, E. S. G., Kastelein, J. J. P., Benardeau, A. M., Kuhlmann, O., Blum, D., Campos, L. A., Clerc, R. G., & Niesor, E. J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00460.x · Cited by 50
Elia, A., & Fossati, S. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1060666 · Cited by 55
Shortall, S. E., Green, A. R., Swift, K., Fone, K. C. F., & King, M. V. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02236.x · Cited by 50
Kobayashi, T., Nogami, T., Taguchi, K., Matsumoto, T., & Kamata, K. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.327 · Cited by 50
Karim, N., Curmi, J., Gavande, N. S., Johnston, G. A. R., Hanrahan, J. R., Tierney, M. L., & Chebib, M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01604.x · Cited by 50
Lozano, D., Fernández‐de‐Castro, L., Portal‐Núñez, S., López‐Herradón, A., Dapía, S., Gómez‐Barrena, E., & Esbrit, P. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01155.x · Cited by 50
Pharmacological dissection of Kv7.1 channels in systemic and pulmonary arteries
Chadha, P. S., Zunke, F., Davis, A. J., Jepps, T. A., Linders, J. T. M., Schwake, M., Towart, R., & Greenwood, I. A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01863.x · Cited by 50
δ‐Aminolevulinic acid is a substrate for the amino acid transporter SLC36A1 (hPAT1)
Frølund, S. U., Marquez, O., Larsen, M., Brodin, B., & Nielsen, C. U. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00620.x · Cited by 50
Matsumoto, T., Kobayashi, T., Ishida, K., Taguchi, K., & Kamata, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00753.x · Cited by 50
Gonadotropes and Gonadotropin-Releasing Hormone Signaling
McArdle, C. A., & Roberson, M. S. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397175-3.00010-7 · Cited by 52
Zhao, J., Su, Y., Zhang, Y., Pan, Z., Yang, L., Chen, X., Liu, Y., Lu, Y., Du, Z., & Yang, B. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00606.x · Cited by 50
Belvisi, M. G., Patel, H. J., Freund‐Michel, V., Hele, D. J., Crispino, N., & Birrell, M. A. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.298 · Cited by 50
Rahman, W., Bannister, K., Bee, L., & Dickenson, A. H. (2011) · Brain Research · doi:10.1016/j.brainres.2011.01.057 · Cited by 50
The Role of G Protein-Coupled Estrogen Receptor (GPER) in Vascular Pathology and Physiology
Xu, F., Ma, J., Wang, X., Wang, X., Fang, W., Sun, J., Li, Z., & Liu, J. (2023) · Biomolecules · doi:10.3390/biom13091410 · Cited by 49
The Intrinsic Cardiac Nervous System: From Pathophysiology to Therapeutic Implications
Giannino, G., Braia, V., Brookles, C. G., Giacobbe, F., D’Ascenzo, F., Angelini, F., Saglietto, A., Ferrari, G. M. D., & Dusi, V. (2024) · Biology · doi:10.3390/biology13020105 · Cited by 56
Koh, E., Yoon, S., & Lee, S. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12229 · Cited by 49
Lecka, J., Rana, M. S., & Sévigny, J. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00951.x · Cited by 49
Haeseler, G., Karst, M., Foadi, N., Gudehus, S., Roeder, A., Hecker, H., Dengler, R., & Leuwer, M. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.255 · Cited by 49
Kanke, T., Kabeya, M., Kubo, S., Kondo, S., Yasuoka, K., Tagashira, J., Ishiwata, H., Saka, M., Furuyama, T., Nishiyama, T., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00342.x · Cited by 49
Livesey, M. R., Cooper, M. A., Deeb, T. Z., Carland, J. E., Kozuska, J. L., Hales, T. G., Lambert, J. J., & Peters, J. A. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802406200 · Cited by 49
Self-citationO'Brien, F., Clarke, G. A., Fitzgerald, P., Dinan, T. G., Griffin, B. T., & Cryan, J. F. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01858.x · Cited by 52
Wong, A., Sagar, D. R., Ortori, C. A., Kendall, D. A., Chapman, V., & Barrett, D. A. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m048694 · Cited by 48
The anti‐nausea effects of CB1 agonists are mediated by an action at the visceral insular cortex
Limebeer, C. L., Rock, E., Mechoulam, R., & Parker, L. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02066.x · Cited by 49
Ca2+paradox injury mediated through TRPC channels in mouse ventricular myocytes
Kojima, A., Kitagawa, H., Omatsu‐Kanbe, M., Matsuura, H., & Nosaka, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00986.x · Cited by 48
Kilpatrick, L. E., Briddon, S. J., Hill, S. J., & Holliday, N. D. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00676.x · Cited by 48
Slack, R. J., & Hall, D. A. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01901.x · Cited by 48
In vitro and in vivo evaluation of the anti‐angiogenic actions of 4‐hydroxybenzyl alcohol
Laschke, M. W., van Oijen, V., Scheuer, C., & Menger, M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01292.x · Cited by 48
Shu, H., Bracamontes, J. R., Taylor, A., Wu, K., Eaton, M. M., Akk, G., Manion, B. D., Evers, A. S., Krishnan, K., Covey, D. F., et al. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01690.x · Cited by 48
Meur, A. M., Ghisdal, P., Mullier, B., Ron, P. D., Downey, P. M., Perren, C. V. D., Declercq, V., Cornelis, S., Famelart, M., van Asperen, J., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12343 · Cited by 47
Freitas, K., Negus, S. S., Carroll, F. I., & Damaj, M. I. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02226.x · Cited by 48
Potassium channels in articular chondrocytes
Mobasheri, A., Lewis, R., Mendes, A. F., Rufino, A. T., Dart, C., & Barrett‐Jolley, R. (2012) · Channels · doi:10.4161/chan.22340 · Cited by 48
Anderson, U. A., Carson, C. E., Johnston, L., Joshi, S., Gurney, A. M., & McCloskey, K. D. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12210 · Cited by 48
Effect of the Itoactivator NS5806 on cloned Kv4 channels depends on the accessory protein KChIP2
Lundby, A., Jespersen, T., Schmitt, N., Grunnet, M., Olesen, S., Cordeiro, J. M., & Calløe, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00859.x · Cited by 48
The Pharmacology of Visceral Pain
Johnson, A. C., & Meerveld, B. G. (2016) · Advances in pharmacology · doi:10.1016/bs.apha.2015.11.002 · Cited by 48
Role of sulfur-containing gaseous substances in the cardiovascular system
Hart, J. L. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e282 · Cited by 48
Sławińska, A., Wierońska, J. M., Stachowicz, K., Marciniak, M., Łasoń, M., Gruca, P., Papp, M., Kusek, M., Tokarski, K., Doller, D., et al. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12254 · Cited by 48
Austin, P. J., Betts, M. J., Broadstock, M., O'Neill, M., Mitchell, S. N., & Duty, S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00820.x · Cited by 48
Anwar, M., Ford, W. R., Broadley, K. J., & Herbert, A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01706.x · Cited by 48
Role of the signal peptide in the synthesis and processing of the glucagon‐like peptide‐1 receptor
Huang, Y., Wilkinson, G. H., & Willars, G. B. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00517.x · Cited by 48
Metadata
- Authors
- Alexander, S., Mathie, A., & Peters, J.
- Affiliations
- University of Nottingham (GB)
- Medway School of Pharmacy (GB)
- University of Dundee (GB)
- ORCID
- Mathie, A
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2011-11
- Volume
- 164
- Issue
- s1
- Pages
- S1-324
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC3315626
- OpenAlex
- W2069380892
- Cited by
- 1,947
- References
- 2
- Citations by year
- 2026: 4 · 2025: 13 · 2024: 12 · 2023: 14 · 2022: 23 · 2021: 19 · 2020: 20 · 2019: 35 · 2018: 27 · 2017: 36 · 2016: 47 · 2015: 59 · 2014: 71 · 2013: 191 · 2012: 279
- FWCI
- 109.61
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- British Journal of Pharmacology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Kent Academic Repository (University of Kent) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion channel regulation and function
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- therapeutic target, G protein-coupled receptors, ligand-gated ion channels, ion channels, nuclear receptors, transporters, enzymes, receptor nomenclature, pharmacological tools
- MeSH terms
- Animals, Humans, Ion Channels, Receptors, Cell Surface, Receptors, Cytoplasmic and Nuclear
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review